Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Oliver Kepp, Laura Senovilla, Ilio Vitale, Erika Vacchelli, Sandy Adjemian, Patrizia Agostinis, Lionel Apetoh, Fernando Aranda, Vincenzo Barnaba, Norma Bloy, Laura Bracci, Karine Breckpot, David Brough, Aitziber Buqué, Maria G. Castro, Mara Cirone, Maria I. Colombo, Isabelle Cremer, Sandra Demaria, Luciana Dini, Aristides G. Eliopoulos, Alberto Faggioni, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Nathalia A. Giese, Zong Sheng Guo, Akseli Hemminki, Martin Herrmann, James W. Hodge, Stefan Holdenrieder, Jamie Honeychurch, Hong-Min Hu, Xing Huang, Tim M. Illidge, Koji Kono, Mladen Korbelik, Dmitri V. Krysko, Sherene Loi, Pedro R. Lowenstein, Enrico Lugli, Yuting Ma, Frank Madeo, Angelo A. Manfredi, Isabelle Martins, Domenico Mavilio, Laurie Menger, Nicolò Merendino, Michael Michaud, Gregoire Mignot, Karen L. Mossman, Gabriele Multhoff, Rudolf Oehler, Fabio Palombo, Theocharis Panaretakis, Jonathan Pol, Enrico Proietti, Jean-Ehrland Ricci, Chiara Riganti, Patrizia Rovere-Querini, Anna Rubartelli, Antonella Sistigu, Mark J. Smyth, Juergen Sonnemann, Radek Spisek, John Stagg, Abdul Qader Sukkurwala, Eric Tartour, Andrew Thorburn, Stephen H. Thorne, Peter Vandenabeele, Francesca Velotti, Samuel T. Workenhe, Haining Yang, Wei-Xing Zong, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Consensus guidelines for the detection of immunogenic cell death. OncoImmunology 3:9.
Read now
Read now
Articles from other publishers (36)
Jun Ni, Xiaoyan Si, Hanping Wang, Xiaotong Zhang & Li Zhang. (2023) Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial. Frontiers in Immunology 14.
Crossref
Crossref
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo, Makoto Nishio, Tony S. K. Mok, Martin Reck, Gene G. Finley, Monika D. Kaul, Wei Yu, Nindhana Paranthaman, Ilze Bāra & Howard J. West. (2023) Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer. JAMA Oncology 9:4, pages 527.
Crossref
Crossref
Pan Zhang, Quan Li, Yuni Zhang, Qianqian Wang, Junfang Yan, Aihua Shen & Burong Hu. (2023) Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in Breast Cancer. International Journal of Environmental Research and Public Health 20:2, pages 1221.
Crossref
Crossref
Naiadja de Santana Cerqueira, Lívia Andrade Vitória, Viviane Palmeira da Silva, Tânia Tavares Rodriguez, Maria Cristina Teixeira Cangussu & Luciana Maria Pedreira Ramalho. (2023) Expression and degranulation of mast cells in laser photobiomodulated mucositis chemo-induced: pilot study in hamsters. Lasers in Medical Science 38:1.
Crossref
Crossref
Mobina Fathi, Kimia Vakili, Kimia Jazi, Mohammad Amin Sadeghi, Mohammadreza Hajiesmaeili, Ashraf Mohamadkhani, Mostafa Rezaei-Tavirani & Arian Tavasol. (2021) Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic. Tumori Journal 108:5, pages 407-419.
Crossref
Crossref
Christophe Glorieux, Xiaojun Xia, Xin You, Zining Wang, Yi Han, Jing Yang, Gauthier Noppe, Christophe de Meester, Jianhua Ling, Annie Robert, Hui Zhang, Sheng-Ping Li, Huamin Wang, Paul J. Chiao, Li Zhang, Xiaobing Li & Peng Huang. (2022) Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer. Journal of Advanced Research 40, pages 109-124.
Crossref
Crossref
Shan-Qiang Zhang, Su-Ming Pan, Shu-Zhen Lai, Hui-Jing Situ, Jun Liu, Wen-Jie Dai, Si-Xian Liang, Li-Qing Zhou, Qi-Qi Lu, Pei-Feng Ke, Fan Zhang, Hai-Bin Chen & Ji-Cheng Li. (2022) Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Kamil Konopka, Paulina Frączek, Maciej Lubaś, Agnieszka Micek, Łukasz Kwinta, Joanna Streb, Paweł Potocki & Piotr Wysocki. (2022) Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. Journal of Clinical Medicine 11:5, pages 1213.
Crossref
Crossref
Hanan Polansky & Benjamin Goral. (2021) How an increase in the copy number of HSV-1 during latency can cause Alzheimer’s disease: the viral and cellular dynamics according to the microcompetition model. Journal of NeuroVirology 27:6, pages 895-916.
Crossref
Crossref
Wei Huang, Jia-Jia Chen, Rui Xing & Yue-Can Zeng. (2021) Combination therapy: Future directions of immunotherapy in small cell lung cancer. Translational Oncology 14:1, pages 100889.
Crossref
Crossref
Chi Li, Howard Donninger, John Eaton & Kavitha Yaddanapudi. (2020) Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope. Frontiers in Immunology 11.
Crossref
Crossref
Chenyue Zhang, Cheng Li, Xiaoling Shang, Jiamao Lin & Haiyong Wang. (2019) Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis. Frontiers in Oncology 9.
Crossref
Crossref
Xiaodong Yang, Yu Shi, Ming Li, Tao Lu, Junjie Xi, Zongwu Lin, Wei Jiang, Weigang Guo, Cheng Zhan & Qun Wang. (2019) Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma. Journal of Translational Medicine 17:1.
Crossref
Crossref
Zhan Zhang, Wei Sang, Lisi Xie & Yunlu Dai. (2019) Metal-organic frameworks for multimodal bioimaging and synergistic cancer chemotherapy. Coordination Chemistry Reviews 399, pages 213022.
Crossref
Crossref
Robert A. Belderbos, Joachim G.J.V. Aerts & Heleen Vroman. (2019) Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment. Molecular Therapy - Oncolytics 13, pages 67-81.
Crossref
Crossref
Hui Liu, Manman Zou, Pei Li, Haifeng Wang, Xijun Lin & Jin Ye. (2019) Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells. Molecular Medicine Reports.
Crossref
Crossref
Hanan Polansky & Hava Schwab. (2018) Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP. Cellular & Molecular Biology Letters 23:1.
Crossref
Crossref
Elena De Mattia, Eva Dreussi, Marcella Montico, Sara Gagno, Chiara Zanusso, Luca Quartuccio, Salvatore De Vita, Michela Guardascione, Angela Buonadonna, Mario D’Andrea, Nicoletta Pella, Adolfo Favaretto, Enrico Mini, Stefania Nobili, Loredana Romanato, Erika Cecchin & Giuseppe Toffoli. (2018) A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy. Frontiers in Pharmacology 9.
Crossref
Crossref
Jakob Nikolas Kather, Niels Halama & Dirk Jaeger. (2018) Genomics and emerging biomarkers for immunotherapy of colorectal cancer. Seminars in Cancer Biology 52, pages 189-197.
Crossref
Crossref
Erika Cecchin, Elena De Mattia, Fabrizio Ecca & Giuseppe Toffoli. (2018) Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Drug Resistance Updates 39, pages 18-40.
Crossref
Crossref
Andrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Lucía Trilla-Fuertes, Jorge M. Arevalillo, Mariana Díaz-Almirón, Hilario Navarro, Paloma Maín, Jaime Feliú, Pilar Zamora, Enrique Espinosa & Juan Ángel Fresno Vara. (2018) Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer. Oncotarget 9:45, pages 27586-27594.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Hans De Reu, Zwi N. Berneman, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion. Frontiers in Immunology 9.
Crossref
Crossref
Thomas Menter & Alexandar Tzankov. (2018) Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. Frontiers in Oncology 8.
Crossref
Crossref
Yueyan Huang, Manxiang Yin, Linlin Pan, Qian Yu, Qifeng Zhu, Weizhen Xu, Baoyue Ding, Yanping Ji & Jifang Zhou. (2018) Solanum nigrum polysaccharide inhibits tumor growth in H22-bearing mice through regulation of caspase-3 and bcl-2. Journal of Cancer Research and Therapeutics 14:Suppl 1, pages S232-S236.
Crossref
Crossref
Julie Jacobs, Vanessa Deschoolmeester, Christian Rolfo, Karen Zwaenepoel, Jolien Van den Bossche, Christophe Deben, Karen Silence, Hans de Haard, Christophe Hermans, Sylvie Rottey, Christel Vangestel, Filip Lardon, Evelien Smits & Patrick Pauwels. (2017) Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy. Oncotarget 8:43, pages 74058-74067.
Crossref
Crossref
Laurie Rangan, Jeanne Galaine, Romain Boidot, Mohamad Hamieh, Magalie Dosset, Julie Francoual, Laurent Beziaud, Jean-René Pallandre, Elodie Lauret Marie Joseph, Afag Asgarova, Christophe Borg, Talal Al Saati, Yann Godet, Jean Baptiste Latouche, Séverine Valmary-Degano & Olivier Adotévi. (2017) Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice. Oncotarget 8:30, pages 48959-48971.
Crossref
Crossref
Leah A. Mitchell, Fernando Lopez Espinoza, Daniel Mendoza, Yuki Kato, Akihito Inagaki, Kei Hiraoka, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly & Joan M. Robbins. (2017) Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model. Neuro-Oncology 19:7, pages 930-939.
Crossref
Crossref
Z Deng, Y Rong, Y Teng, X Zhuang, A Samykutty, J Mu, L Zhang, P Cao, J Yan, D Miller & H-G Zhang. (2016) Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene 36:5, pages 639-651.
Crossref
Crossref
Bruna Cerbelli, Angelina Pernazza, Andrea Botticelli, Lucio Fortunato, Massimo Monti, Paolo Sciattella, Domenico Campagna, Federica Mazzuca, Maria Mauri, Giuseppe Naso, Paolo Marchetti, Giulia d’Amati & Leopoldo Costarelli. (2017) PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?. BioMed Research International 2017, pages 1-7.
Crossref
Crossref
Barbara Ingold Heppner, Sibylle Loibl & Carsten Denkert. (2016) Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer. Breast Care 11:2, pages 96-100.
Crossref
Crossref
Sathana Dushyanthen, Paul A. Beavis, Peter Savas, Zhi Ling Teo, Chenhao Zhou, Mariam Mansour, Phillip K. Darcy & Sherene Loi. (2015) Relevance of tumor-infiltrating lymphocytes in breast cancer. BMC Medicine 13:1.
Crossref
Crossref
Guoshuai Cao, Jian Wang, Xiaodong Zheng, Haiming Wei, Zhigang Tian & Rui Sun. (2015) Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6. Journal of Biological Chemistry 290:50, pages 29964-29973.
Crossref
Crossref
J. Jacobs, V. Deschoolmeester, K. Zwaenepoel, C. Rolfo, K. Silence, S. Rottey, F. Lardon, E. Smits & P. Pauwels. (2015) CD70: An emerging target in cancer immunotherapy. Pharmacology & Therapeutics 155, pages 1-10.
Crossref
Crossref
Craig D. Logsdon, Thiruvengadam Arumugam & Vijaya Ramachandran. (2015) Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. American Journal of Physiology-Gastrointestinal and Liver Physiology 309:5, pages G283-G291.
Crossref
Crossref
Hatem H. Soliman, Erica Jackson, Tony Neuger, E. Claire Dees, R. Donald Harvey, Hyo Han, Roohi Ismail-Khan, Susan Minton, Nicholas N. Vahanian, Charles Link, Daniel M. Sullivan & Scott Antonia. (2014) A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors. Oncotarget 5:18, pages 8136-8146.
Crossref
Crossref
J. Löhr, Stephan Haas, Jens Kröger, Helmut Friess, Raimund Höft, Peter Goretzki, Christian Peschel, Markus Schweigert, Brian Salmons & Walter Gunzburg. (2014) Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer. Pharmaceutics 6:3, pages 447-466.
Crossref
Crossref